IART Integra LifeSciences Holdings Corporation

Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference

Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference

PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at .

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit .  

Investor Relations:

Chris Ward

(609) 772-7736

   

Media Contact:

Laurene Isip

(609) 208-8121

  

Integra LifeSciences Holdings Corporation



EN
04/09/2024

Underlying

IARTIntegra LifeSciences Holdings Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Reports First Quarter 2025 Financial Results

Integra LifeSciences Reports First Quarter 2025 Financial Results PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 Highlights First quarter revenues of $382.7 million increased 3.7% on a reported basis and decreased 3.5% on an organic basis compared to the prior year. First quarter GAAP earnings per diluted share of $(0.33), compared to $(0.04) in the prior year; adjusted earnings per diluted share of $0.41, compared to $0.55...

May 5, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Host First Quarter 2025 Financial Results Conf...

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in detail...

April 18, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthc...

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeScien...

March 13, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financi...

Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Reported revenues were $442.6 million, representing an increase of 11.5% on a reported basis and an increase of 3.5% on an organic basis compared to the fourth quarter 2023. GAAP earnings per diluted share were $0.25, compared to $0.25 in the fourth quarter 2023. Adjusted earnings per dilut...

February 25, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financi...

Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on...

February 4, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch